The Indian Council of Agricultural Research has introduced a new vaccine to combat African Swine Fever, a highly contagious disease that has caused significant economic losses in the pig farming sector since 2020. This breakthrough aims to reduce high mortality rates and provide a long-term solution for farmers, replacing previous control methods like culling.
The Indian Council of Agricultural Research has officially announced the development of an indigenous vaccine against African Swine Fever, a critical step in addressing a disease that has caused severe financial strain on India's livestock sector. The vaccine, developed at the National Institute of High Security Animal Diseases in Bhopal, uses an attenuated virus strain to provide immunity against the highly contagious pathogen.
Economic Impact and Disease History
Since its first emergence in India in 2020, African Swine Fever has caused widespread disruption in pork production chains. Because the disease is highly lethal, with mortality rates often reaching 100%, previous control measures were limited to quarantine, biosecurity protocols, and the culling of infected animals. The economic consequences have been substantial for smallholder farmers, particularly in the North-Eastern states. For example, outbreaks in Assam between 2020 and 2021 resulted in estimated losses of ₹276 crore, while reports indicate that ASF outbreaks in Mizoram impacted over 11,300 households with losses estimated at ₹982 crore through 2025.
Scientific Validation and Next Steps
To ensure safety and efficacy, the vaccine has undergone rigorous laboratory testing and field trials conducted alongside the Department of Animal Husbandry and Dairying. The testing focused on immunogenicity, safety, and genetic stability to ensure the virus does not revert to a harmful state. By providing a preventative tool, the vaccine is expected to reduce the necessity for mass culling, which has historically been the primary, albeit destructive, method for managing outbreaks.
For the agricultural and animal health sector, this development represents a shift from reactive containment to proactive disease management. The next critical monitorables for the industry and relevant stakeholders include the large-scale manufacturing timeline, the distribution strategy to reach small farmers in remote areas, and the final regulatory roadmap for commercial rollout. Successful deployment of the vaccine could stabilize pork production supply chains and protect the livelihoods of thousands of farmers who depend on pig rearing as a primary source of income.